Trifluoroacetic Acid

Trifluoroacetic Acid

SCHEMBL2453867

CC(=O)Oc1ccc(NC(=O)c2ccc(N3CCNCC3)cc2)cc1.O=C(O)C(F)(F)F

nearest known ligand 0.58

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 10/20 0.53
KMT2A Q03164 6/20 0.53
ALDH1A1 P00352 5/20 0.53
RAB9A P51151 4/20 0.53
MCL1 Q07820 2/20 0.53
NR4A1 P22736 1/20 0.53
HSD17B10 Q99714 3/20 0.51
USP2 O75604 3/20 0.51
NPC1 O15118 3/20 0.51
ALOX15 P16050 2/20 0.51
MEN1 O00255 3/20 0.50
KDM4E B2RXH2 3/20 0.50
SMN1; SMN2 Q16637 3/20 0.50
SLC2A1 P11166 2/20 0.49
MAPKAPK2 P49137 2/20 0.48
ATM Q13315 1/20 0.48
HIF1A Q16665 1/20 0.48
TP53 P04637 1/20 0.47
MAPK1 P28482 1/20 0.47
LMNA P02545 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12306050 0.92 MAPT (0.60) MAPTKMT2AALDH1A1RAB9AMCL1
Trifluoroacetic Acid SCHEMBL5333651 0.89 MAPT (0.46) MAPTKMT2AALDH1A1RAB9AMCL1
Trifluoroacetic Acid SCHEMBL29803762 0.89 RAB9A (0.56) MAPTKMT2AALDH1A1RAB9AMCL1
Trifluoroacetic Acid SCHEMBL5333653 0.86 MAPT (0.46) MAPTKMT2AALDH1A1RAB9AHSD17B10
SCHEMBL27694104 0.83 MAPT (0.57) MAPTKMT2AALDH1A1RAB9AMCL1
SCHEMBL27694107 0.83 MAPT (0.57) MAPTKMT2AALDH1A1RAB9AMCL1
SCHEMBL2453870 0.81 RAB9A (0.54) MAPTKMT2AALDH1A1RAB9AMCL1
SCHEMBL22495337 0.81 MAPT (0.79) MAPTKMT2AALDH1A1RAB9AMCL1
SCHEMBL24891825 0.80 RAB9A (0.64) MAPTKMT2AALDH1A1RAB9AMCL1
SCHEMBL1663115 0.79 ALDH1A1 (0.66) MAPTKMT2AALDH1A1RAB9AMCL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1799663-B1 Modulators of HCV replication ANGELETTI P IST RICHERCHE BIO (IT) 2012-08-01 EP disclosed
US-8012982-B2 Modulators of HCV replication ISTITUTO DI RICERCHE BIOLOGIA MOLECOLARE P. ANGELETTI SPA (IT) 2011-09-06 US disclosed
US-20090069344-A1 Modulators of hcv replication ISTITUTO DI RICERCHE BIOLOGIA MOLECOLARE P. ANGELETTI SPA (IT) 2009-03-12 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090069344-A1 Modulators of hcv replication EIF2AK2, IRF3, IFNAR1 MAPT 4662/4885KMT2A 3871/4885ALDH1A1 3229/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.